Feds Can't Dodge Gilead HIV Patent Counterclaims
A Delaware federal judge Thursday denied the federal government's bid to toss Gilead Sciences' counterclaims in a case accusing the biotech company of infringing four government-owned patents for an HIV treatment....To view the full article, register now.
Already a subscriber? Click here to view full article